A-Alpha Bio is a provider of cell-based tools for quantitative and high-throughput measurements of protein interactions, accelerating target discovery, library screening, and preclinical drug characterization. A-Alpha Bio utilizes its proprietary AlphaSeq technology to map protein-protein interactions at a high scale and resolution. This technology can identify and quantify interactions between thousands of protein pairs simultaneously. By providing detailed maps of protein interactions, A-Alpha Bio aids in the identification of potential drug targets and the understanding of disease mechanisms. This can significantly streamline the process of discovering new therapeutics. A-Alpha Bio is a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck.

Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

Adyn is a precision medicine company that develops personalized birth control methods. It provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control to fertility and beyond. The company's first product, the Birth Control Optimization Test, is an at-home kit enabling users to collect both saliva and finger prick samples to measure hormone baseline levels and aims to assess genetic risk for blood clots and depression. Adyn's technology then synthesizes a medical biography with side effect profiles of estrogens and progestins used in hormonal contraception. Elizabeth Ruzzo headquartered the company in Seattle, Washington in 2019 and is backed by Lux Capital, M13, Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, and Ascend VC.

Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of genetic medicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.

Aeva develops a sensing and perception paradigm for autonomous machines. Its technology brings together the best of vision, depth, and motion sensors into a single product with superior performance. Compared to today's best in class, it provides greater range and resolution across weather conditions and a new dimension to precisely measure velocity of every pixel in the scene. Founded in 2016, Aeva is based in Mountain View, California.

Called a Godsend by The New York Times, Aira is on a mission to make the world accessible anywhere, anytime. They provide on-remand, remote visual interpretation services for the blind and low vision community. Download the app, press a button and your phone's camera streams a live video to one our highly screened Visual Interpreters.

AirMap is helping make drones a part of everyday life by building the foundations for the low-altitude air navigation systems of the future. The emergence of small, powerful, and autonomous drones, is transforming society. Drones are being used for agriculture, public safety, aerial photography and cinematography, and soon, package delivery. The next century of aviation innovation is happening at the local level, not across oceans, and it's happening below 500 feet. AirMap is organizing this low altitude information so innovation can take flight. AirMap works collaboratively with industry partners to create the future for drones. It focuses exclusively on providing airspace information so that others in the nascent industry can build amazing vehicles and applications. AirMap is a member of the Small UAV Coalition and the NASA Unmanned Traffic Management (UTM) program.

Alife develops artificial intelligence tools to assist physicians in increasing a patient's chances of pregnancy success. The company has a mission of helping people have healthy children and connects fertility specialists to patients to assists with IVF. Alife Health was founded in 2020 by Paxton Maeder-York and is headquartered in San Francisco, California, United States.

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Anchorage Digital is a regulated crypto platform that provides institutions with integrated financial services and infrastructure solutions.

Anduril Industries is a defense product company that builds technology for military agencies and border surveillance. Anduril commits top technical talent to solve complex national security challenges. The company is building the next generation of technology that will aid and protect those who serve on the front lines defending the nation and its interests. Andurils' mission is to develop innovative technology that enables America and its allies to maintain global leadership now and into the future.

Applied Intuition is a vehicle software supplier that accelerates the adoption of safe and intelligent machines worldwide. Founded in 2017, Applied Intuition provides a simulation and validation platform for various industries such as automotive, trucking, construction, and more. 18 of the top 20 global automakers rely on Applied Intuition’s solutions to shorten development cycles, deliver high-quality systems, and accelerate the production of modern vehicles with confidence.